Ethris' has four potential drugs under development pipeline, of which one is for treating uncontrolled asthma and three other for primary c...

Emcure Pharmaceuticals and its subsidiary Gennova have resolved all legal disputes with US-based HDT Bio Corp. The parties have entered int...

The US district judge James Robart upheld the Indian drug maker's argument that the court lacked jurisdiction over the company and dismisse...

The Coalition for Epidemic Preparedness Innovations (CEPI) and Gennova Biopharmaceuticals have announced a new funding agreement to develop...

The mRNA-based vaccine was developed by Gennova Biopharmaceuticals using the indigenous platform technology, and supported under the Missio...

As Covid-19 cases saw an uptick in other countries, the government in November approved Bharat Biotech's intranasal vaccine iNCOVACC for he...

Moderna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before CO...

Gennova had in April submitted interim data on India's first indigenously developed mRNA Covid-19 vaccine to the Central Drug Standard Cont...

Gennova Biopharmaceuticals, a subsidiary of Pune-based drugmaker Emcure Pharmaceuticals, is developing a Covid-19 vaccine on its mRNA platf...

The company had submitted the interim Phase-1 clinical trial data to CDSCO, where it tested for safety and immunogenicity.

The Paris-based company said it will continue to develop another vaccine candidate that is already undergoing late stage human trials. That...

While almost 1 billion people have been fully vaccinated in China, the country is still lacking an mRNA shot, with most of the population i...

To assess the immunogenicity of the mRNA vaccine, Gennova will have to use Covishield — an existing vaccine — as a comparator, as the regul...

The team comprises Professor Raghavan Varadarajan, Dr. Mrinmoy De and Dr. SiddharthJhunjhunwala (IISc), and Dr. Amit Awasthi (Translational...

Providence will sell up to 30 million doses of its mRNA vaccine, PTX-COVID19-B, to Biological E., and will also provide the necessary techn...

On Friday, senior executives from companies such as Moderna, GSK and Bharat Biotech addressed various issues on Covid vaccines, including e...

The DBT said it has approved additional funding towards clinical studies of India's first of its kind' mRNA-based COVID-19 vaccine, HGCO19,...